HMG CoA reductase inhibitor associated myositis and autoimmune hepatitis (Letter)
File version
Author(s)
Mantha, Murty
Dheda, Shyam
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
The use of statins is increasing. Although both autoimmune hepatitis and statin related myopathy have been reported to occur following commencement of statin therapy, they have not been reported to occur in the same patient. We present such a case and her clinical course. Stains are widely prescribed in the chronic kidney disease (CKD) population. They have been known to unmask or initiate immune-mediated disease
Journal Title
Internal Medicine Journal
Conference Title
Book Title
Edition
Volume
47
Issue
10
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Cardiovascular medicine and haematology
Clinical sciences
Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
STATINS
Persistent link to this record
Citation
Palamuthusingam, D; Mantha, M; Dheda, S, HMG CoA reductase inhibitor associated myositis and autoimmune hepatitis, Internal Medicine Journal, 2017, 47 (10), pp. 1213-1215